Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin A randomized, 52-week, double-blind, active-controlled noninferiority trial - Nauck, M A; Del Prato, S; Meier, J J (Diabetes Care, 2011)
et al.